Tag: ARQL

Finance

Why Need to Watch: ArQule Inc. (NASDAQ:ARQL), Texas Instruments Inc. (NASDAQ:TXN), Rhino Resource Partners LP (NYSE:RNO), United Technologies (NYSE:UTX), W.R. Berkley (NYSE:WRB)

ArQule Inc. (NASDAQ:ARQL) announced that eight presentations of clinical and pre-clinical data on three early clinical-stage product candidates took place during the 26th EORTC-NCI-AACR Symposium held November 18-21, 2014 in Barcelona, Spain. ArQule Inc. (NASDAQ:ARQL) belongs to Healthcare sector. Its weekly performance is 6.25%. On last trading day company shares ended up $1.36. ArQule Inc. (NASDAQ:ARQL) distance from 50-day simple moving average (SMA50) is 17.50%. … Continue reading Why Need to Watch: ArQule Inc. (NASDAQ:ARQL), Texas Instruments Inc. (NASDAQ:TXN), Rhino Resource Partners LP (NYSE:RNO), United Technologies (NYSE:UTX), W.R. Berkley (NYSE:WRB)

Harvey Dyer
Finance

Investors Are Watching : Time Warner Inc. (NYSE:TWX), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Allegheny Technologies Inc. (NYSE:ATI), ArQule Inc. (NASDAQ:ARQL), USMD Holdings, Inc. (NASDAQ:USMD)

Time Warner Inc. (NYSE:TWX) cut its ties to Time Inc., the once-great magazine publisher. The Tribune Company, keeping its television stations, has created a separately traded entity called Tribune Publishing for its newspapers. News Corp. now holds Rupert Murdoch’s newspapers, while 21st Century Fox has his entertainment properties. E. W. Scripps sent its papers packing. Time Warner Inc. (NYSE:TWX) belongs to Services sector. Its net … Continue reading Investors Are Watching : Time Warner Inc. (NYSE:TWX), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Allegheny Technologies Inc. (NYSE:ATI), ArQule Inc. (NASDAQ:ARQL), USMD Holdings, Inc. (NASDAQ:USMD)

John Bellich
Finance

New Lows: ArQule, Inc. (NASDAQ:ARQL), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG), TrovaGene Inc (NASDAQ:TROV)

ArQule, Inc (NASDAQ:ARQL) CEO Paolo Pucci purchased 5,000 shares of the company’s stock in a transaction dated Tuesday, May 20th. The stock was purchased at an average cost of $1.42 per share, with a total value of $7,100.00. Following the transaction, the chief executive officer now directly owns 232,280 shares of the company’s stock, valued at approximately $329,838. ArQule, Inc. (NASDAQ:ARQL) stock performance was -2.76% … Continue reading New Lows: ArQule, Inc. (NASDAQ:ARQL), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG), TrovaGene Inc (NASDAQ:TROV)

Mark Doerr
Finance

Biotech New Lows: ArQule (NASDAQ:ARQL), OvaScience Inc (NASDAQ:OVAS), Uniqure (NASDAQ:QURE), Egalet Corp (NASDAQ:EGLT)

ArQule Inc. (NASDAQ:ARQL) announced that the Company will present at the Needham 13th Annual Healthcare Conference. The presentation will be web cast and may be accessed through the investor relations section of the Company’s website http://www.arqule.com. ArQule, Inc. (NASDAQ:ARQL) stock performance was -2.92% in last session and finished the day at $1.66. Traded volume was 530,559.00million shares in the last session and the average volume … Continue reading Biotech New Lows: ArQule (NASDAQ:ARQL), OvaScience Inc (NASDAQ:OVAS), Uniqure (NASDAQ:QURE), Egalet Corp (NASDAQ:EGLT)

Colin Pettis